The most significant change is the loss of the hemidesmosomal laminin-332 (see further text) in invasive prostate carcinoma, that is, its LAMA3, LAMB3, and LAMC2 subunits, which might be epigenetically silenced in prostate cancer [185]. The gene discussed is LAMC2; the disease is prostate carcinoma.